Stock comparison
Medtronic
Organon &
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MDT
Medtronic
Market cap
$97.84B
Sector
Healthcare
OGN
Organon &
Market cap
$3.52B
Sector
Healthcare
Overall winner
Medtronic MDT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MDT | OGN | Winner |
|---|---|---|---|
| Warren Buffett | 50C | 43D | MDT |
| Benjamin Graham | 57C | 72B | OGN |
| Philip Fisher |
Side-by-side metrics
| Metric | MDT | OGN |
|---|---|---|
| Market cap | $97.84B | $3.52B |
| P/E (TTM) | 21.2x | 14.2x |
| EV/EBIT | 21.0x | 2.7x |
| ROIC (TTM) | 6.43% | 51.64% |
| Gross margin | 61.95% | 53.11% |
| Net margin | 13.0% | 3.99% |
| Revenue CAGR 5y | 2.73% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MDT leads on
- EPS CAGR 5y7.88%vs -39.38%+120%
- Revenue CAGR 5y2.73%vs -0.35%+113%
- Market cap$97.84Bvs $3.52B+96%
- Debt / Equity0.6xvs 9.5x
More like OGN
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.